Treatment of HRD-positive ovarian carcinosarcoma: A case report and literature review.

Lin, Xin Yi; Xu, Huang Zhen; Liang, Chen; Zhao, Ai Yue

Lin, Xin Yi; Xu, Huang Zhen; Liang, Chen; Zhao, Ai Yue.

Affiliation

Lin XY; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Xu HZ; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Liang C; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zhao AY; Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Electronic address: 15715979968@163.com.

Asian J Surg ; 46(12): 6047-6048, 2023 Dec.

Article de En | MEDLINE | ID: mdl-37743176

Sujet(s)
Mots clés

Gynecologic tumor; HRD-Positive; Malignant mixed mullerian duct tumor; Ovarian cancer sarcoma; PARP inhibitor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Carcinosarcome Limites: Female / Humans Langue: En Journal: Asian J Surg Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google